Sort   by:  
 Page size 
UnknownCytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial.
Not available
S-EPMC7408501 | biostudies-literature
UnknownFunctional Improvement Trajectories After Surgery (FIT After Surgery) study: protocol for a multicentre prospective cohort study to evaluate significant new disability after major surgery in older adults.
Not available
S-EPMC9226941 | biostudies-literature
UnknownClinical phenotype of the recurrent 1q21.1 copy-number variant.
Not available
S-EPMC7263044 | biostudies-literature
UnknownPatient and caregiver involvement in implementing health research in chronic kidney disease: a workshop report.
Not available
S-EPMC11880764 | biostudies-literature
UnknownThe cognitive and behavioral phenotype of the 16p11.2 deletion in a clinically ascertained population.
Not available
S-EPMC5410712 | biostudies-literature
UnknownA 600 kb deletion syndrome at 16p11.2 leads to energy imbalance and neuropsychiatric disorders.
Not available
S-EPMC3494011 | biostudies-literature
UnknownDefining the Effect of the 16p11.2 Duplication on Cognition, Behavior, and Medical Comorbidities.
Not available
S-EPMC5894477 | biostudies-literature
UnknownPlasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer: the STAMPEDE Phase 3 Randomized Clinical Trial.
Not available
S-EPMC11869088 | biostudies-literature
UnknownCasirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8830904 | biostudies-literature
UnknownTocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355 | biostudies-literature
Sort   by:  
 Page size